Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study
Berthele A, Goedel C, Kallmann B, Kowarik M, Lehmann-Horn K, Marziniak M, Meyer C, Rauer S, Rothhammer V, Sprenger T, Wildemann BC, Schirduan K (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: SAGE PUBLICATIONS LTD
City/Town: LONDON
Pages Range: 940-941
Conference Proceedings Title: MULTIPLE SCLEROSIS JOURNAL
Event location: Amsterdam
Authors with CRIS profile
Involved external institutions
Technische Universität München (TUM)
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Eberhard Karls Universität Tübingen
Germany (DE)
Universitätsklinikum Leipzig
Germany (DE)
ms zentrum bamberg
Germany (DE)
kbo-Isar-Amper-Klinikum gemeinnützige GmbH
Germany (DE)
Biogen GmbH
Germany (DE)
HELIOS Kliniken
Germany (DE)
Albert-Ludwigs-Universität Freiburg
Germany (DE)
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Eberhard Karls Universität Tübingen
Germany (DE)
Universitätsklinikum Leipzig
Germany (DE)
ms zentrum bamberg
Germany (DE)
kbo-Isar-Amper-Klinikum gemeinnützige GmbH
Germany (DE)
Biogen GmbH
Germany (DE)
HELIOS Kliniken
Germany (DE)
Albert-Ludwigs-Universität Freiburg
Germany (DE)
How to cite
APA:
Berthele, A., Goedel, C., Kallmann, B., Kowarik, M., Lehmann-Horn, K., Marziniak, M.,... Schirduan, K. (2022). Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study. In MULTIPLE SCLEROSIS JOURNAL (pp. 940-941). Amsterdam, NL: LONDON: SAGE PUBLICATIONS LTD.
MLA:
Berthele, A., et al. "Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study." Proceedings of the 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam LONDON: SAGE PUBLICATIONS LTD, 2022. 940-941.
BibTeX: Download